Chad M. Robins, CEO and Chairman at Adaptive Biotechnologies Corp (ADPT), sold 91,467 shares at $3.43 ($314K) on 2024-03-05, disclosed to the SEC on 2024-03-06.
Seasonal sale ($314k) by CEO and Chairman — this insider has traded ADPT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.43 | 42,794 | $147K | 46.8% |
| 2 | $3.43 | 42,794 | $147K | 46.8% |
| 3 | $3.44 | 5,879 | $20K | 6.4% |
| Total | $3.43 avg | 91,467 | $314K | 100% |
| Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |
| ADPT | SELL | 2026-03-03 | $8.3M | — | Filing → |
| ADPT | SELL | 2026-02-04 | $2.3M | — | Filing → |